Silvana Battaglia - Jun 22, 2023 Form 4 Insider Report for agilon health, inc. (AGL)

Role
Director
Signature
/s/ Steven Meetre, as Attorney-in-Fact
Stock symbol
AGL
Transactions as of
Jun 22, 2023
Transactions value $
$0
Form type
4
Date filed
6/26/2023, 05:26 PM
Previous filing
Mar 13, 2023
Next filing
Jul 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGL Common Stock Award $0 +8.96K $0.00 8.96K Jun 22, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGL Options (Right to buy) Award $0 +19.3K $0.00 19.3K Jun 22, 2023 Common Stock 19.3K $16.74 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This grant of restricted stock units under the agilon health, inc. 2021 Omnibus Equity Incentive Plan (the "Plan") will vest in full on June 22, 2024, subject to the reporting person's continued service as a director.
F2 Includes restricted stock units.
F3 This option grant under the Plan will become exercisable in three equal installments on each anniversary of the grant date, commencing on June 22, 2024, subject to the reporting person's continued service as a director.